BLT about to announce they have dosed their first human patient in a HCV P1/P2 FDA approved trial.
150 patients (out licensed) have been dosed using BLTs ddrnai tech and have been proven safety and efficacy.
This is still a very gobsmackingly undervalued stock. Must be the most non-brainer stock decision of this decade.
Get in while you can.
But hey DYOR.
All biotechs smashing it this year! go biotechs!! people past fear seems to be fading.
Read closely all the HCV trials going on and exactly what they require. BLT potentially smashes all of them. One injection. All 3 genotypes. Cure. Not a band aid solution. Hep B, Lung Cancer, Pain Management to follow soon as in house progrmas. 31.5m just raised with sophisticated american investors. Same ones that Arrowhead used and then became a ten bagger virtually overnight. The list goes on.
